Europe Neuroendoscopy Devices Market

Europe Neuroendoscopy Devices Market Size (2022 To 2027)

The European neuroendoscopy devices market is anticipated to grow at a CAGR of 5.83% during the forecast period. The market size is expected to grow from USD 65.08 million in 2022 to USD 86.4 million by 2027.

The growing prevalence of brain tumors in the European region is one of the key factors driving the European neuroendoscopy devices market growth. According to a study, an estimated 4-11 cases per 100,000 men and 2-9 cases per 100,000 women brain tumor cases can be seen in the European population. These people prefer to have neuroendoscopy surgeries, due to which the demand for neuroendoscopy devices is growing considerably in the European region. In addition, the growing pediatric brain tumors are favoring the regional market growth. The growth of abnormal cells in the brain of the child results in the cause of various brain tumors, such as noncancerous and cancerous. To detect differences between them, neuro endoscopy devices are used to take a sample from the brain, which helps for better treatment in the future. Furthermore, the presence of special care centers for the care of children who are ill in the European region is boosting the market growth in Europe.

In addition, the growing preference towards minimally invasive surgeries is expected to fuel the growth rate of the European neuroendoscopy devices market. Neuroendoscopy is a minimally invasive surgery in which a neuroendoscopy device is used to visualize and access the human body's intracranial and spinal spaces. The awareness among healthcare providers and people regarding the advantages associated with minimally invasive surgeries has grown significantly in recent years, boosting the growth of neuroendoscopy devices in Europe.

Furthermore, the growing adoption of technological developments to manufacture advanced neuroendoscopy devices is expected to promote the market’s growth rate in Europe. Fiber optics neuro endoscopy devices are specially manufactured for children's brain surgeries. Owing to the increasing number of people suffering from brain disorders, manufacturers are focusing on developing neuro endoscopy devices with affordable costs for hospitals and developing high-quality devices for significant surgeries.

On the other end, the high costs of neuroendoscopy procedures hamper European market growth. In addition, factors such as the scarcity of skilled professionals and lack of advanced healthcare infrastructure in the hospital for brain tumor surgery in some European countries are hindering the neuroendoscopy devices market growth in Europe.

This research report on the Europe neuroendoscopy devices market has been segmented and sub-segmented into the following categories.

By Product:

• Rigid Endoscopes
• Flexible Endoscopes

By Application:

• Transnasal Neuroendoscopy
• Intraventricular Neuroendoscopy
• Transcranial Neuroendoscopy

 By Usability:

• Reusable Endoscopes
• Disposable Endoscopes

By Patient’s Age:

• Adult Patient
• Paediatric Patient

By End-Use:

• Hospitals
• Ambulatory Surgical Centres
• Diagnostic Centres
• Others

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The European market accounted second biggest share of the global market in 2021, and the North American region held the first place. However, the European neuroendoscopy devices market is expected to register a prominent CAGR owing to the growing aging population and rising R&D activities around neuroendoscopy devices.

During the forecast period, the German market is estimated to capture a considerable share of the European market. The presence of skilled healthcare providers that can perform successful neuroendoscopy surgeries in Germany is one of the factors contributing to the market growth in Germany. In addition, the growing number of neuroendoscopy training courses and the rising number of healthcare providers, particularly for neuroendoscopy surgeries, support the German market expansion. Furthermore, the growing incidence of primary brain tumors in aged people, resulting in multiple comorbidities and polypharmacy, decreased tolerance to chemotherapy, and an increased risk for radiation-induced neurotoxicity fuel the market’s growth rate in Germany.

The UK is expected to witness a notable CAGR during the forecast period owing to the rising awareness regarding the availability of neuroendoscopy surgeries for brain-related problems, such as tumors, cysts, and others among the UK population. In addition, healthcare organizations' increasing number of awareness programs regarding the symptoms of brain tumors and available neuroendoscopy surgeries as treatments is further expected to promote the UK market growth.

KEY MARKET PLAYERS:

Tonglu Wanhe Medical, B. Braun Aesculap, Karl Storz, Clarus Medical, LocaMed, Machida, VisionSense, ClearMind Biomedical, evonos, Ackermann Instrumente and Schindler are some of the notable companies in the European neuroendoscopy devices market.